Skip to main content

Table 2 Values on measures amongst participants in the observation phase at each time point

From: Evaluation of a smartwatch-based intervention providing feedback of daily activity within a research-naive stroke ward: a pilot randomised controlled trial

Outcome

Baseline

3 weeks

12 weeks/3 months

M (SD)

Median (range)

M (SD)

Median (range)

M (SD)

Median (range)

Performance-based

 Grip strength (Kg)

  Right

17 (12.4)

 

18 (13.7)

   

  Left

14 (11.4)

 

12 (12.3)

   

 10-m walk test (s)

41 (28.4)

 

52 (52.7)

   

 MoCA

14 (6.2)

13 (4–26)

17 (4.8)

18 (7–25)

  

 BI

11 (4.5)

10 (4–20)

11 (3.5)

11 (6–17)

  

Self-report

 FSS

 

43 (15–63)

 

51 (11–61)

  

 VAF-S

 

6 (0–10)

 

7 (2–10)

  

 EQ-5D-5L VAS

57 (26.2)

60 (10–100)

59 (26.8)

65 (0–100)

56 (16.5)

60 (30–85)

 RMI

 

6 (1–14)

 

8 (1–12)

 

9 (0–15)

 WHODAS

 

45 (18–83)

 

53 (33–77)

 

44 (12–100)

  1. Data were included only if the patient successfully completed assessment.
  2. Abbreviations: MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index; FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item). M (SD), mean and standard deviation. WHODAS scores represent a percentage of the maximum disability score (the total score, between 0 and 48, is divided by 48 and multiplied by 100)
Back to article page

Pilot and Feasibility Studies

ISSN: 2055-5784